Berhyanda gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The state of the healthcare services will improve substantially with the involvement and participation of ULBs
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Subscribe To Our Newsletter & Stay Updated